Top Markets
#1 PulseChain PulseChain +45.13%
#2 Glidr Glidr +11.05%
#3 Fake World Assets Fake World Assets +9.47%
#4 Meteora Meteora +7.99%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.90%
#6 eCash eCash +6.72%
#7 Qkacoin Qkacoin +6.49%
#8 OPENLOOT OPENLOOT +5.89%
#9 Velvet Velvet +5.57%
#10 Tornado Cash Tornado Cash +5.56%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Oxygenta Pharmaceutical Ltd. Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.

OXYGENTAPH
Rank in Stocks #28278
Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of... Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.
Share Price
$0.74183167
Last synced: 2026-08-19
Market Cap
$27.44M
Change (1 day)
-0.01%
Change (1 year)
-20.70%
Country
IN
Trade Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)

Category

Healthcare
P/E ratio for Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)
P/E ratio as of 2026 TTM: 0
According to Oxygenta Pharmaceutical Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Oxygenta Pharmaceutical Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.13 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.